Related Experiment Video
Updated: Nov 14, 2025

Quasi-metagenomic Analysis of Salmonella from Food and Environmental Samples
Published on: October 25, 2018
Complete Genome Sequence of Stenotrophomonas maltophilia Siphophage Salva
Brandi Jefferson1, Guichun Yao2, James Clark3
1Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas, USA.
Abstract:
Stenotrophomonas maltophilia is a Gram-negative pathogen causing severe and often refractory illnesses such as pneumonia and bacteremia. We present the genome of phage Salva, a novel S. maltophilia phage that is not closely related to any phages currently deposited in GenBank. The genome is 60,789 bp, containing 102 putative protein-coding genes.
Insights
Researchers sequenced the genome of phage Salva, a novel bacteriophage targeting Stenotrophomonas maltophilia. This discovery offers new insights into S. maltophilia phages, potentially aiding in combating infections.
Area of Science:
- Microbiology
- Genomics
- Bacteriophage Research
Background:
- Stenotrophomonas maltophilia is a Gram-negative bacterium responsible for severe, difficult-to-treat infections like pneumonia and bacteremia.
- Novel therapeutic strategies are needed to combat infections caused by antibiotic-resistant pathogens like S. maltophilia.
Purpose of the Study:
- To present the complete genome sequence of a novel bacteriophage, Salva, targeting Stenotrophomonas maltophilia.
- To characterize the genetic makeup of phage Salva and assess its novelty compared to existing phage databases.
Main Methods:
- Genome sequencing of the novel bacteriophage Salva.
- Bioinformatic analysis to identify putative protein-coding genes.
- Comparative genomic analysis against existing phage sequences in GenBank.
Main Results:
- The genome of phage Salva was sequenced and found to be 60,789 base pairs in length.
- The genome contains 102 putative protein-coding genes.
- Phage Salva is not closely related to any previously characterized S. maltophilia phages in GenBank, indicating its novelty.
Conclusions:
- The characterization of phage Salva provides a new genomic resource for S. maltophilia research.
- This novel phage represents a potential candidate for phage therapy against S. maltophilia infections.
- Further studies are warranted to explore the lytic activity and therapeutic potential of phage Salva.
Related Concept Videos
DNA Bacteriophages
Sanger Sequencing

